2018 to 2024 saw rise in insurance denials for brand-name drugs

Medical Xpress

Insurance denials of initial attempts to fill brand-name prescription drugs with no generic competitors increased by more than two-thirds from 2018 to 2024, according to a study published online in the Journal of the American Medical Association. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

2018 to 2024 saw rise in insurance denials for brand-name drugs

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Rapid bacterial community profiling of equine microbiomes using Oxford Nanopore sequencing

Women with PMOS at four-fold higher risk of heart disease

Electyrolyzer experiment designated ready-to-fly by NASA

Medical Xpress의 다른 기사

Latest evidence on risk factors, early intervention, and strategies to prevent heart failure before symptoms develop

Research suggests more patients with pre-existing disabilities could benefit from thrombectomy

Exploring safer surgical tools to reduce swallowing complications after spine surgery